From CNBC: 2024-09-12 17:29:25

Adobe shares dropped over 10% after issuing soft guidance, with a fourth-quarter revenue forecast of $5.50 to $5.55 billion, below analyst estimates. Oracle’s revenue guidance increase led to a nearly 6% stock bump. Neurocrine Biosciences fell over 2% on disappointing schizophrenia drug trial results, while RH surged 19% on strong earnings. Aptiv PLC shares rose 1.7% after CEO purchased 30,000 shares.

Read more: Stocks making the biggest moves after hours: ADBE, RH, ORCL